Human ovarian mesothelial cells and methods of isolation and uses thereof
The invention discloses a substantially pure population of human ovarian mesothelial cells and methods of isolating and culturing the ovarian mesothelial cells. By carefully manipulating the microenvironment of the ovarian mesothelial cells, multiple passages are attainable wherein the ovarian mesothelial cells are capable of becoming ovary surface epithelial cells or granulosa cells. In addition, several methods of use of human ovarian mesothelial cells are disclosed herein.
1. A method of providing a source of immunogen to a heterologous recipient, comprising administering a plurality of ovarian mesothelial cells in an amount effective to induce an immune response in said recipient, wherein said ovarian mesothelial cells have a pluripotent capacity to differentiate into ovary surface epithelial cells or granulosa cells.
2. A method of generating human ovarian tissue models in non-human mammalian recipients, comprising administering a plurality of human ovarian mesothelial cells into said recipients, wherein said ovarian mesothelial cells are first maintained in basal nutrient and then administered at a location within said recipient, said location being able to support growth and differentiation of said ovarian mesothelial cells, and wherein said ovarian mesothelial cells have a pluripotent capacity to differentiate into ovary surface epithelial cells or granulosa cells.
3. A method of providing cell therapy to a recipient, comprising administering human ovarian mesothelial cells into said recipients, wherein said ovarian mesothelial cells are first grown in nutrient media and then administered at a location within said recipient, said location being able to support growth and differentiation of said ovarian mesothelial cells, and wherein said ovarian mesothelial cells have a pluripotent capacity to differentiate into ovary surface epithelial cells or granulosa cells.